(Reuters) -Eli Lilly hit $1 trillion in market value on Friday, making it the first drugmaker to enter the exclusive club dominated by tech giants and underscoring its rise as a weight-loss powerhouse.
Here are some reactions to Lilly joining the trillion dollar club:
EVAN SEIGERMAN, ANALYST AT BMO CAPITAL MARKETS
"The current valuation points to investor confidence in the longer-term durability of the company's metabolic health franchise. It also suggests that investors prefer Lilly over Novo in the obesity arms race. Taking a step back, we're also seeing money rotate into the sector as investors may be worried about an AI bubble."
HANK SMITH, DIRECTOR & HEAD OF INVESTMENT STRATEGY AT LILLY SHAREHOLDER HAVERFORD TRUST
"Investors have historically liked secure earnings growth and (Eli Lilly) is the only large cap pharma that has that kind of earnings profile."
(Reporting by Siddhi Mahatole and Shashwat Chauhan in Bengaluru; Editing by Leroy Leo)
latest_posts
- 1
Extravagance SUVs for Seniors: Solace, Innovation, and Security - 2Figure out How to Pick a Crematorium: Key Contemplations.
- 3Hungary's 'water guardian' farmers fight back against desertification
- 4The most effective method to Offset Album Rates with Liquidity Needs
- 5Figuring out the Justification for Separation: To blame and No-Shortcoming
- 'The best gift ever': Baby is born after the rarest of pregnancies, defying all odds
- Nature: 10 High priority Setting up camp Spots In Europe
- Independence from the rat race: How to Save and Contribute Shrewdly
- The most effective method to Go with Informed Choices on Vehicle Leases
- Wegmans recalls mixed nuts over salmonella contamination fears
- Wedding Guest Outraged That Bride and Groom, Who Are in Their 60s and Have Both Been Married Before, Registered for Gifts
- If someone's always late, is it time blindness, or are they just being rude?
- What is the 'Survivor 50' Challenge? Hidden immunity idols will be up for grabs in every U.S. state.
- Top Frozen yogurt Flavor: Cast Your Vote!
